Baxter Intl: Analyst Sentiments and 12-Month Price Targets

Baxter Intl has been assessed by 5 financial analysts, with evolving sentiments in the past 30 days. The average 12-month price target is $32.4, a 5.81% decrease from the previous average of $34.40. Analysts have provided diverse opinions, with 1 being somewhat bullish, 2 indifferent, and 1 somewhat bearish.

In recent months, Baxter International Inc. (BAX) has been subject to varying analyst opinions, with five financial experts offering diverse assessments. The sentiments towards BAX have evolved over the past 30 days, as summarized in the table below:

| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish |
|---------|------------------|-------------|------------------|---------|
| 0 | 0 | 0 | 1 | 0 |
| 0 | 0 | 0 | 1 | 0 |
| 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 |

The average 12-month price target for BAX is $32.4, a 5.81% decrease from the previous average of $34.40 [1]. Analysts have provided a range of opinions, with one somewhat bullish, two indifferent, and one somewhat bearish.

Key insights from analyst actions include:

- Patrick Wood of Morgan Stanley lowered his rating to 'Underweight' with a current price target of $27.00, down from $28.00 [1].
- Joanne Wuensch of Citigroup lowered her rating to 'Neutral' with a current price target of $32.00, down from $34.00 [1].
- Vijay Kumar of Evercore ISI Group lowered his rating to 'Outperform' with a current price target of $42.00, down from $44.00 [1].
- Larry Biegelsen of Wells Fargo lowered his rating to 'Equal-Weight' with a current price target of $33.00, down from $36.00 [1].

These updates reflect analysts' reactions to recent market conditions and company performance. The diverse opinions highlight the varying expectations for BAX's future performance.

References:
[1] https://www.benzinga.com/insights/analyst-ratings/25/07/46417553/assessing-baxter-intl-insights-from-5-financial-analysts
[2] https://stockinvest.us/stock/BAX